ArticleExperimental hematology & oncology2022

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis.

Chenghao Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.